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The peritoneal equilibration test (PET) is a standardized procedure to assess peritoneal membrane performance in patients on continuous ambulatory peritoneal dialysis (CAPD) . ' The results of this test allow clinicians to prescribe the most suitable of the CAPD regimes now available, and are also helpful in establishing the cause of dialysis failure.
The PET lasts for 4 h, during which dialysate samples are taken at 0 h, 2 h and 4 h for glucose and creatinine measurement, and a blood sample at 2 h for creatinine measurement. The dialysates have very high glucose concentrations (up to 125 mmol/L) which cause interference in the Jaffk reaction used to estimate creatinine.2 Awareness of this effect led Twardowski' to quote a correction equation of the form:
Corrected creatinine = Apparent creatinine -F x glucose A value for the factor F was provided by the laboratory analysing his PET samples. A similar factor (0-853, when creatinine concentrations are in pmol/L and glucose in mmol/L) is also given in worksheets provided by Baxter Healthcare for the recording of PET result^,^ in which it is suggested that the quoted factor may be used if none is provided by the laboratory analysing the samples. In our experience this resulted in negative creatinine concentrations in some cases and we questioned the validity of the indiscriminate use of this factor.
To study variations in the extent of glucose interference between different analysers and methods, identical samples from one patient's PET were analysed in five laboratories by a variety of creatinine methods.
METHODS AND MATERIALS
Aliquots of dialysate samples A to D were sent out to the participating laboratories with a Correspondence: Miss S C Farrell questionnaire requesting creatinine estimation, date of receipt and analysis of samples, and details of the method and analyser used. Samples B, C, and D were, respectively, the 0 h, 2 h and 4 h samples from a PET, and sample A was a blank dialysate fluid containing no creatinine. The samples were also analysed by four methods in our laboratory, including a manual enzymatic method using creatininase, creatinase, and sarcosine oxidase (Creatinine PAP kit, Boehringer Mannheim UK, Lewes, UK). Table 1 . Samples were received by all laboratories on the day after posting, and were analysed on that day with the exception of those sent to one laboratory, which were stored at 4°C until analysis five days later (the second set of Astra 8 results). The samples to be analysed in our laboratory were kept at ambient temperature overnight to mimic the conditions of those in the post, and subsequently stored at 4°C. The glucose concentrations of samples A to D were 117, 111, 62, and 50mmol/L, respectively. These were measured on the day the samples were despatched, and again after two days storage at 4°C. There was no change in either glucose concentration or apparent creatinine concentration over this time period.
RESULTS

Results are shown in
The corrected creatinine results in Table 1 are calculated from the results obtained from the Beckman creatinine analyser, using the following equation which was determined specifically for this analyser: 0.999 x ac)-(0.281 xg) -9.25 where cc = corrected creatinine in pmol/L, ac = apparent creatinine in pmol/L, and g = glucose in mmol/L. Apparent creatinine concentrations were measured in dialysis fluids of known glucose and creatinine content, and the equation was obtained by multiple regression of glucose and apparent creatinine concentrations on true creatinine concentration, using a commercially available statistical software package (Minitab, Minitab lnc., State College, PA, USA).
DISCUSSION
As expected there was a variation in the creatinine concentrations reported, which suggests different degrees of interference with different methods. The creatininase-based enzymatic method is not subject to glucose interference, therefore these results are likely to be the most accurate; furthermore there is good agreement between these results and the Beckman results corrected using our experimentally derived equation.
A wide range of Jaffk methods was used, with different concentrations of picrate and hydroxide, different wavelengths, different sample to reagent ratios, and different times of absorbance reading, depending on the reagents and analyser parameters used. A further difference is between methods using an endpoint absorbance and kinetic methods which use a rate measurement over a specific time period. Too wide a range of Jaffk methods was used in this study to draw any conclusions about the conditions which cause the least interference, and in any case manipulation of a method solely to minimize interference in dialysates is not a practical solution for the routine of the laboratory. The enzymatic method is expensive, and we feel that the correction factor approach is the most practical, since dialysate glucose determinations are required for the PET in any case. It is important, however, to be aware that a correction factor of this type applies to one analyser/method alone, and that the use of any other factor is invalid.
